May 09, 2019 - RVNC earnings call for the period ending March 31, 2019.
May 09, 2019 - Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2019 Earnings Conference Call May 08, 2019, 16:30 ET Company Participants Jeanie Herbert - Senior Director, IR & Corporate Communications Daniel Browne
May 01, 2019 - Revance (RVNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mar 01, 2019 - Revance Therapeutics Inc (RVNC) Files 10-K for the Fiscal Year Ended on December 31, 2018, Stocks: RVNC, release date:Mar 01, 2019
Feb 26, 2019 - Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2018 Earnings Conference Call February 26, 2019 4:30 PM ET Company Participants Jeanie Herbert - Senior Director of Investor Relations and Corporate Communi
Feb 26, 2019 - RVNC earnings call for the period ending December 31, 2018.
Feb 05, 2019 - Allergan's (AGN) stock declines almost 4% after FDA approves Evolus' Jeuveau injection to treat frown lines, which can pose strong competition to Botox.
Nov 01, 2018 - Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2018 Earnings Conference Call November 1, 2018, 16:30 ET Executives Jeanie Herbert - Senior Director of IR & Corporate Communications Daniel Browne - Co
Jul 17, 2018 - Revance Therapeutics Sees Hammer Chart Pattern: Time to Buy?
May 30, 2018 - Revance Therapeutics (RVNC) announced Tuesday morning that Lauren Silvernail has resigned as its Chief Financial Officer and Chief Business Officer.